Effectiveness of t-graft (vein in the left internal thoracic artery) in mininvasive coronary shunting in patients with IBS
Abstract
Objective: to evaluate the efficacy and safety of T-graft (vein in LVGA) application in mini-invasive coronary artery bypass grafting in patients with CHD.
Material and methods: Retrospectively from October 2012 to February 2023, 1111 patients who underwent CABG from mini-invasive access were analysed for inclusion. Thirty-six (3.2%) cases (T-graft at CB) were included in the study. Primary endpoint was mortality, secondary endpoints were parameters such as: myocardial infarction, stroke and wound infections. The mean age was 67.9 ± 14.2 years (48 to 85 years). Gender: males 24 (66.6%) and females 12 (33.4%). Mean EuroSCORE II score: 3.6 ± 1.4.
Results: There was no mortality in the study group. All operations were performed on a beating heart. The average operation time was 136 ± 34 min. The average number of distal anastomoses was 2. There were no complications related to the operation such as: postoperative bleeding, wound infection and stroke. The average length of stay in the intensive care unit was 1.7 ± 0.7 days. The mean duration of hospitalization was 7.9 ± 1.2 days. The mean follow-up period was 42.4 months (95% CI 36.4.1-46.7). Kaplan-Meier survival estimate showed a 36-month survival rate of 97.8% (95% CI 97.1-99).
Conclusions: The use of T-graft in mini-invasive coronary artery bypass grafting for myocardial revascularization is an effective and safe procedure that demonstrates good immediate and mid-term surgical outcomes in patients with CHD.
About the Authors
M. S. Fomenko
FSBI “Federal Center for High Medical Technologies”, Ministry of Health of the Russian Federation (FGBU “FCVMT”, Ministry of Health of the Russian Federation)
Russian Federation
Russian Federation
236035, Kaliningrad region, Guryevsky district, Rodniki settlement, Kaliningradskoye sh., d. 4. 4.
tel. 8(4012)592 000
fax 8(4012)592 198
Y. A. Shneider
FSBI “Federal Center for High Medical Technologies”, Ministry of Health of the Russian Federation (FGBU “FCVMT”, Ministry of Health of the Russian Federation)
Russian Federation
Russian Federation
236035, Kaliningrad region, Guryevsky district, Rodniki settlement, Kaliningradskoye sh., d. 4. 4.
tel. 8(4012)592 000
fax 8(4012)592 198
V. G. Tsoi
FSBI “Federal Center for High Medical Technologies”, Ministry of Health of the Russian Federation (FGBU “FCVMT”, Ministry of Health of the Russian Federation)
Russian Federation
Russian Federation
236035, Kaliningrad region, Guryevsky district, Rodniki settlement, Kaliningradskoye sh., d. 4. 4.
tel. 8(4012)592 000
fax 8(4012)592 198
P. A. Shilenko.
FSBI “Federal Center for High Medical Technologies”, Ministry of Health of the Russian Federation (FGBU “FCVMT”, Ministry of Health of the Russian Federation)
Russian Federation
Russian Federation
236035, Kaliningrad region, Guryevsky district, Rodniki settlement, Kaliningradskoye sh., d. 4. 4.
tel. 8(4012)592 000
fax 8(4012)592 198
A. A. Pavlov
FSBI “Federal Center for High Medical Technologies”, Ministry of Health of the Russian Federation (FGBU “FCVMT”, Ministry of Health of the Russian Federation)
Russian Federation
Russian Federation
236035, Kaliningrad region, Guryevsky district, Rodniki settlement, Kaliningradskoye sh., d. 4. 4.
tel. 8(4012)592 000
fax 8(4012)592 198
References
1. Head SJ, Milojevic M, Daemen J, et al. Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data. // Lancet 2018;391:939-48. doi: 10.21037/jtd.2018.08.127
2. Kopjar T, Dashwood MR, Dreifaldt M, de Souza DR. No-touch saphenous vein as an important conduit of choice in coronary bypass surgery. // J Thorac Dis. 2018 Sep;10(Suppl 26):S3292-S3296. doi: 10.21037/jtd.2018.08.127.
3. Kim MS, Hwang HY, Kim JS, Oh SJ, Jang MJ, Kim KB. Saphenous vein versus right internal thoracic artery as a Y-composite graft: Five-year angiographic and clinical results of a randomized trial. // J Thorac Cardiovasc Surg. 2018 Oct;156(4):1424-1433.e1. doi: 10.1016/j.jtcvs.2018.04.123.
4. Kim MS, Kim KB. Saphenous Vein Versus Right Internal Thoracic Artery as a Y-Composite Graft: TenYear Angiographic and Long-Term Clinical Results of the SAVE RITA Trial. // Circulation. 2021 Oct 5;144(14):1186- 1188. doi: 10.1161/CIRCULATIONAHA.121.056438.
5. Kim KB, Hwang HY, Kim MS. Techniques and Outcomes of the No-Touch Vein Conduit as a Y-Composite Graft. // Braz J Cardiovasc Surg. 2022 Sep 2;37(Spec 1):38-41. doi: 10.21470/1678-9741-2022-0119.
6. Hwang HY, Lee Y, Sohn SH, Choi JW, Kim KB. Equivalent 10-year angiographic and long-term clinical outcomes with saphenous vein composite grafts and arterial composite grafts. // J Thorac Cardiovasc Surg. 2021;162(5):1535-43.e4. doi:10.1016/j.
7. Samano N, Geijer H, Liden M, et al. The no-touch saphenous vein for coronary artery bypass grafting maintains a patency, after 16 years, comparable to the left internal thoracic artery: A randomized trial. J Thorac Cardiovasc Surg 2015;150:880-8. DOI: 10.1016/j.jtcvs.2015.07.027.
8. Royse AG, Bellomo R, Royse CF, Clarke-Errey S, Boggett S, Kelly T, et al. Radial artery vs bilateral mammary composite Y coronary artery grafting: 15- year outcomes. // Ann Thorac Surg. 2021;111(6):1945- 53. doi:10.1016/j.athoracsur.2020.08.019
9. Sohn SH, Lee Y, Choi JW, Hwang HY, Kim KB. Bilateral internal thoracic artery in situ versus Y-composite graftings: long-term outcomes. // Ann Thorac Surg. 2020;109(6):1773-80. doi:10.1016/j.athoracsur.2019.09.057.
10. Kim MS, Hwang HY, Cho KR, Kim KB. Right gastroepiploic artery versus right internal thoracic artery composite grafts: 10-year patency and long-term outcomes. // J Thorac Cardiovasc Surg. 2022;163(4):1333- 43.e1. doi:10.1016/j.jtcvs.2020.05.096.
Review
For citations:
Fomenko M.S., Shneider Y.A., Tsoi V.G., Shilenko. P.A., Pavlov A.A. Effectiveness of t-graft (vein in the left internal thoracic artery) in mininvasive coronary shunting in patients with IBS. Minimally Invasive Cardiovascular Surgery. 2024;3(3):21-77. (In Russ.)
Views:
16
Email this article 